N🟁N

WHG, DGX, SAPE, THRX, GPRO, COL, Expected to Trade Lower After Bearish Insider Trading

December 6, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. WESTWOOD HOLDINGS GROUP, INC. (NYSE:WHG), QUEST DIAGNOSTICS INCORPORATED (NYSE:DGX), SAPIENT CORPORATION (NASDAQ:SAPE), THERAVANCE, INC. (NASDAQ:THRX), GEN-PROBE INC. (NASDAQ:GPRO), ROCKWELL COLLINS, INC. (NYSE:COL) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).

The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.

     Symbol     Company Name                        Insider Name                        Role        Shares         Insider Score     Avg 6 Month Return     # of Dec. 
     WHG        WESTWOOD HOLDINGS GROUP, INC.       Casey, Brian O                      CEO         24,654         80                -7.4%                  4         
     DGX        QUEST DIAGNOSTICS INCORPORATED      Hagemann, Robert A                  CFO         4,150          100               -9.8%                  30        
     SAPE       SAPIENT CORPORATION                 Oversohl, Christian                 O           15,900         84                -16.7%                 5         
     THRX       THERAVANCE, INC.                    Shafer, Bradford J                  GC          20,000         90                -28.0%                 5         
     GPRO       GEN-PROBE INC.                      Dewalt, Diana R                     O           5,000          84                -14.1%                 8         
     COL        ROCKWELL COLLINS, INC.              Abzug, Barry M                      O           4,323          83                -10.4%                 5         

The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.

WESTWOOD HOLDINGS GROUP, INC. (NYSE:WHG) - Westwood Holdings Group, Inc. manages investment assets and provides services for its clients. The company operates through two subsidiaries, Westwood Management Corp. and Westwood Trust. Westwood Management Corp. is a registered investment advisor, and provides investment advisory services to corporate and public retirement plans, endowments, foundations, the WHG Funds, other mutual funds, and clients of Westwood Trust. Westwood Trust provides trust services and participation in common trust funds that it sponsors to institutions and high net worth individuals. Westwood Holdings Group, Inc. was founded in 1983 and is based in Dallas, Texas.

QUEST DIAGNOSTICS INCORPORATED (NYSE:DGX) - Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. It offers patients and physicians the access to diagnostic testing services through its network of laboratories and patient service centers; and interpretive consultation services. The company provides commercial clinical testing services, including routine clinical testing for blood chemistries, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, routine microbiology testing, prescription drug monitoring, alcohol and other substance-abuse tests, and allergy tests; gene-based and esoteric testing; and anatomic pathology services, as well as risk assessment services for the life insurance industry. It also develops and integrates clinical connectivity and data management solutions for healthcare organizations, physicians, and clinicians through its Care360 suite of products; and offers Centergy Data Exchange and the ChartMaxx electronic document management system to hospitals. In addition, the company provides central laboratory testing services in connection with clinical research trials on new drugs, vaccines, and medical devices; and clinical testing to employers for the detection of employee use of drugs-of-abuse. Further, it develops and manufactures products that enable healthcare professionals to make healthcare diagnoses, including HerpeSelect ELISA tests that detect patient antibodies to certain types of herpes simplex virus, and sells to academic medical centers, hospitals, and commercial laboratories; White Blood Cell Analyzer for performing whole-blood test on finger-stick samples; and InSure fecal immunochemical test for screening for colorectal cancer. The company was founded in 1967 and is headquartered in Madison, New Jersey.

SAPIENT CORPORATION (NASDAQ:SAPE) - Sapient Corporation helps clients to leverage marketing and technology to transform their businesses. The company offers integrated marketing and creative services, including visual concept, design, and implementation through multiple media; brand building and direct response programs; customer loyalty strategies; customer relationship strategy and implementation; and integrated advertising campaigns. It provides Web and interactive development services, such as user interface design and development; site design and development; custom application development; user research and testing; content management and technology development and implementation; and quality assurance testing. Its traditional advertising services comprise brand strategy, copywriting, creative advertising, and production for print, radio, and television campaigns. The company offers media planning and buying services that include media strategy development, Website search engine marketing, email marketing, online advertising, viral and social media marketing, emerging channels marketing, and gaming. Its strategic planning and marketing analytics services consist of brand strategy development, consumer and market research, advertising message content, Internet and blogosphere analytics and coordination, and management of online and print media. The company offers commerce technologies; business applications, such as custom and package applications, enterprise resource planning, supply chain solutions, and Web solutions; advisory services comprising strategy alignment, subject matter expertise, process and architecture definition, program management, and training; and analytics services. It offers its services to financial services, consumer and travel, energy services, government, health and education, and automotive and industrial sectors. The company markets its services primarily in North America and Europe. Sapient Corporation was founded in 1990 and is headquartered in Boston, Massachusetts.

THERAVANCE, INC. (NASDAQ:THRX) - Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines across various therapeutic areas, including respiratory disease, bacterial infections, and gastrointestinal motility dysfunction. Its key programs include VIBATIV with Astellas Pharma, Inc. approved in the United States and Canada for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant and methicillin-susceptible strains; RELOVAIR with GlaxoSmithKline (GSK), a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease and/or asthma; and the Bifunctional Muscarinic Antagonist-beta2 Agonist program with GSK, which completed Phase 2a. The companys other pipeline programs under various clinical-stages comprise TD-1211, an oral peripheral Mu-opioid antagonist for the treatment of opioid-induced constipation; TD-5108 and TD-8954, 5HT-4 agonists for the treatment of gastrointestinal motility dysfunction and/or Alzheimers disease; TD-1792, an antibiotic for the treatment of serious infections caused by Gram-positive bacteria; and MARIN program (TD-9855) for the treatment of chronic pain. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance was founded in 1996 and is headquartered in South San Francisco, California.

GEN-PROBE INC. (NASDAQ:GPRO) - Gen-Probe Incorporated engages in the development, manufacture, and marketing of nucleic acid tests used primarily to diagnose human diseases and screen donated human blood in North America and internationally. The company markets a portfolio of products to detect infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, and other infections. Its primarily product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The companys product line also include APTIMA HIV-1 assay to detect RNA from HIV-1, the virus that causes AIDS; APTIMA HCV assay to detect RNA from the hepatitis C virus; and ASRs for quantitative HCV testing to quantify HCV viral load. It also offers Pro-Flu+, Pro-Flu ST, ProGastro Cd, AMPLIFIED MTD, and GAS Direct for various respiratory infectious diseases; LIFECODES HLA DNA typing kits and LIFECODES LifeScreen antibody screening kits in the transplant diagnostics field; Procleix HIV-1/HCV assay, Procleix Ultrio assay, Procleix Ultrio Plus assay, and Procleix WNV assay for the blood donor screening market; and TIGRIS and Direct Tube Sampling instrument systems to develop instrumentation. In addition, the companys developing products include PANTHER, an automated testing instrument. Further, the company offers PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 gene. The companys customers include reference laboratories, public health institutions, and hospitals. It has a collaboration agreement with Novartis Vaccines and Diagnostics, Inc. for the research, development, and manufacturing of its blood screening products. The company was founded in 1983 and is headquartered in San Diego, California.

ROCKWELL COLLINS, INC. (NYSE:COL) - Rockwell Collins, Inc. engages in the design, production, and support of communications and aviation electronics for commercial and military customers worldwide. It operates in two segments, Government Systems and Commercial Systems. The Government Systems segment provides communication and electronic systems, products, and services, which include communications systems and products, military data link systems and products, navigation systems and products, subsystems for the flight deck, cockpit display systems, integrated computer systems, and simulation and training systems, as well as offers maintenance, repair, parts, and after-sales support services. It offers its products and services for airborne and surface applications to the U.S. Department of Defense, local and state governments, other government agencies, civil agencies, defense contractors and foreign ministries of defense. The Commercial Systems segment supplies aviation electronics systems, products, and services to original equipment manufacturers of commercial air transport, business and regional aircraft, commercial airlines, and fractional interest and other business aircraft operators. Its products include integrated avionics systems, integrated cabin electronics systems, communications systems and products, navigation systems and products, situational awareness and surveillance systems and products, electro-mechanical systems, and simulation and training systems. This segment also provides on-board information management systems and connectivity solutions, airborne and ground applications and services, and ground infrastructure and services; and maintenance, repair, parts, and after-sales support services. The company was founded in 1933 and is headquartered in Cedar Rapids, Iowa.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net